A Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures

NCT01618695 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

940

Enrollment

INDUSTRY

Sponsor class

Conditions

Partial-onset Seizures

Interventions

DRUG: Perampanel
DRUG: Placebo

Sponsor

Eisai Co., Ltd.